{"": [74, 83, 0, 84, 1475, 0], "Abbreviations": [1476, 2253, 0], "INTRODUCTION": [2254, 6942, 0], "Computational": [6965, 7855, 0], "Recombinant protein production": [7856, 10302, 0], "Peptide and glycan analyses by mass spectrometry": [10303, 10790, 0], "Size exclusion chromatography (SEC)": [10813, 11241, 0], "Hydrophobic interaction chromatography (HIC)": [11242, 11997, 0], "Differential scanning calorimetry (DSC)": [11998, 12500, 0], "Accelerated stability assays": [12501, 12811, 0], "Biophysical analyses": [10791, 12811, 1], "Reactivity with convalescent sera": [12812, 14190, 0], "EXPERIMENTAL SECTION": [6943, 14190, 1], "Design, production, and purification of RBD variants": [14200, 16465, 0], "Glycan analysis": [16466, 17279, 0], "Biophysical characterization and ACE2\u2010binding": [17280, 20404, 0], "Seroreactivity of RBD variants": [20405, 22738, 0], "RESULTS": [14191, 22738, 1], "DISCUSSION": [22739, 30816, 0], "CONFLICT OF INTEREST": [30817, 31012, 0], "Supporting information": [31013, 31100, 0]}